Les prodrogues sont des dérivés biologiquement inactifs d’un principe actif qui, après administration à un organisme, subissent une transformation chimique ou enzymatique pour libérer le principe actif au site d’action. Elles améliorent les propriétés physicochimiques du principe actif pour permettre un meilleur transport à travers les barrières biologiques et pour augmenter l’activité in vivo. Elles sont utilisées pour améliorer la formulation et l’administration, accroître la perméabilité et l’absorption, modifier le profil de distribution et éviter le métabolisme et la toxicité. Cette approche est très utile pour améliorer l'administration de principes actifs. Il existe deux types de prodrogues : les prodrogues liées à un transporteur et les bioprécurseurs. Dans le premier cas, la molécule active est liée par une liaison covalente à un groupement temporaire, ce qui fournit une nouvelle molécule, qui est inactive. Le groupement temporaire libéré ne doit pas avoir, par lui-même, d'action pharmacologique ni de toxicité. Dans le second cas, le principe actif est transformé métaboliquement ou chimiquement par réaction d’hydratation, d’oxydation ou de réduction. Les azapeptides sont des mimes peptidiques dans lesquels un ou plusieurs carbones de la chaîne peptidique sont remplacés par des atomes d’azote. Ce remplacement augmente la rigidité de la chaîne peptidique et favorise le repliement de type β. Le repliement β des azapeptides est associé à plusieurs propriétés thérapeutiques. Certains azapeptides ont montré une meilleure activité, une meilleure sélectivité et une plus grande stabilité comparativement aux peptides parents ce qui prolonge leur durée d'action et les rend plus résistants aux dégradations métaboliques. Ce mémoire s’intéresse particulièrement à l’azapeptide : [aza(p-MeO)F⁴]-GHRP-6. Celui-ci est un analogue du peptide sécréteur d’hormone de croissance 6 (GHRP-6, H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂), qui possède une affinité pour deux récepteurs distincts : les récepteurs de growth hormone secretagogue receptor 1a (GHS-R1a) et le récepteur cluster of differentiation 36 (CD36). L’[aza(p-MeO)F⁴]-GHRP-6 démontre une sélectivité envers le récepteur CD36 offrant des possibilités de traitement de maladies telles que l’athérosclérose et la dégénérescence maculaire liée à l’âge (DMLA). De plus, le récepteur CD36 peut interagir avec un corécepteur toll-like receptor 2 (TLR2), et l’[aza(p-MeO)F⁴]-GHRP-6 peut réduire des réponses immunitaires innées. La stratégie des prodrogues a été utilisée dans ce mémoire pour augmenter la durée d’action de l’azapeptide [aza(p-MeO)F⁴]-GHRP-6. Plus précisément, cinq analogues des prodrogues α-acyloxyéthylcarbamates de l’aza(p-MeO)F⁴-GHRP-6 ont été synthétisées. Ce mémoire présente la première synthèse de prodrogues α-acyloxyéthylcarbamates à caractère PEG de l’[aza(p-MeO)F⁴]-GHRP-6. / A prodrug is a biologically inactive derivative of a drug which after administration undergoes chemical or enzymatic modification to release the active drug at targeted sites of activity. Prodrugs improve physicochemical properties to enable better transport through biological barriers and enhance activity. They are used to improve formulation and administration, to enhance permeability and absorption, to modify distribution profiles and to avoid metabolism and toxicity. The prodrug approach is useful for improving drug delivery. Prodrugs are classified into two types: carrier-linked prodrugs and bio-precursors. In the first case, the parent drug is linked by a covalent bond to an inert carrier or transport moiety. The carrier should not be active or toxic. The active drug is released by a chemical or enzymatic cleavage in vivo. In the second case, the parent drug is converted metabolically or chemically by hydration, oxidation or reduction reactions. Azapeptides employ a semicarbazide as an amino amide surrogate in a peptide analog in which the backbone α-CH is replaced by nitrogen. Through electronic interactions, the semicarbazide favors backbone β-turn geometry due to a combination of urea planarity and hydrazine nitrogen lone pair – lone pair repulsion. Azapeptides have proven therapeutic utility. Some of them exhibit better selectivity, activity and stability than the parent peptides with increased duration of action and improved metabolic stability. Growth hormone releasing peptide-6 (GHRP-6, H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂) is a synthetic peptide possessing an affinity for two different receptors: growth hormone secretagogue receptor 1a (GHS-R1a) and cluster of differentiation receptor 36 (CD36). The GHRP-6 azapeptide analogue, [aza(p-MeO)F⁴]-GHRP-6, has exhibited good affinity for CD36 and reduced nitric oxide overproduction in macrophage cells stimulated with the TLR-2 agonist R-FSL-1. Azapeptide ligands of CD36, such as [aza(p-MeO)F⁴]-GHRP-6, offers potential as prototypes for developing treatments of diseases such as atherosclerosis and age-related macular degeneration. A prodrug strategy has been pursued to improve the pharmacokinetic properties, such as duration of action, of [aza(p-MeO)F⁴]-GHRP-6. The first examples of α-acyloxyethyl carbamate peptides have been prepared. Five α-acyloxyethyl carbamate analogues of [aza(p-MeO)F⁴]-GHRP-6 have been synthesized by routes featuring acylation of the resin-bound peptide using different activated α-acyloxyethyl carbonates prior to resin cleavage and side chain deprotection. The evaluation of the activity of the pharmacokinetic properties of the [aza(p-MeO)F⁴]-GHRP-6 prodrugs is currently in progress and will be reported in due time.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / This work describes the reaction parameters influence in the 3,5-dimethyl-1H-pyrazole N-alkylation under microwave irradiation. The experiments were performed in different conditions with the purpose of verified the influence of temperature, basic, pressure, solvent effect and ionic liquid effect as passive heating elements (PHEs). The used alkylant agents were 1-butyl bromide, 2-butyl bromide, 1-ethyl iodide, 1-ethyl bromide and 1-butyl chloride. The ionic liquids [BMIM][BF4], [EMIM][BF4], [OMIM][BF4] and [BPy][BF4] were applied as PHEs. Initially, it was possible verified which elevated temperatures (100 - 150°C) allows to perform the reaction in very short reaction times (2,5 - 10 min). In general, it was observed which the base need is related to low reaction temperatures and alkylant agents of low reactivity. In addition, enhanced conversions were obtained with the solvent polarity and/or internal pressure increase. When different ionic liquids were used as PHEs, no relevant conversion difference was observed to the studied reaction. / Este trabalho descreve a influência dos parâmetros reacionais sobre a N-alquilação de 3,5-dimetil-1H-pirazol assistida por irradiação de micro-ondas. Os experimentos foram conduzidos em diferentes condições a fim de verificar a influência da temperatura, base, pressão, efeito do solvente e efeito do líquido iônico como elemento passível de aquecimento (EPA). Como agentes alquilantes, foram utilizados 1-bromobutano, 2-bromobutano, 1-iodoetano, 1-bromoetano e 1-clorobutano. Os líquidos iônicos [BMIM][BF4], [EMIM][BF4], [OMIM][BF4] e [BPy][BF4] foram utilizados como EPAs. Através dos experimentos realizados, foi possível verificar que elevadas temperaturas (100 - 150°C) permitem a utilização de curtos tempos reacionais (2,5 - 10 min). De modo geral, foi observado que a necessidade de base está relacionada a baixas temperaturas reacionais e agentes alquilantes de baixa reatividade. Além disso, melhores conversões foram obtidas com o aumento da polaridade do solvente e/ou da pressão interna do vaso reacional. Quando diferentes líquidos iônicos foram utilizados como EPAs, não foram observadas diferenças significativas de conversão para a reação estudada.

Submitted by Fernanda Stuani Pereira null (ferstuani@hotmail.com) on 2016-06-22T22:22:49Z No. of bitstreams: 1 Tese-FERNANDA STUANI PEREIRA.pdf: 6105856 bytes, checksum: 653cf59956934017da496664aa74e886 (MD5) / Approved for entry into archive by Ana Paula Grisoto (grisotoana@reitoria.unesp.br) on 2016-06-24T17:11:14Z (GMT) No. of bitstreams: 1 pereira_fs_dr_prud.pdf: 6105856 bytes, checksum: 653cf59956934017da496664aa74e886 (MD5) / Made available in DSpace on 2016-06-24T17:11:14Z (GMT). No. of bitstreams: 1 pereira_fs_dr_prud.pdf: 6105856 bytes, checksum: 653cf59956934017da496664aa74e886 (MD5) Previous issue date: 2016-06-09 / Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) / O presente trabalho descreve modificações estruturais feitas na cadeia lateral do polímero quitosana mediante a N-alquilação com diferentes aldeídos aromáticos, a qual originam bases de Schiff como produtos intermediários, seguido de uma redução com cianoborohidreto de sódio (NaBH3CN). Subsequentemente, reações de acoplamento entre o produto sintetizado N-benzil quitosana e diferentes sais de diazônio foram realizadas para produzir uma nova classe de compostos poli-azóicos a partir deste polímero. Diferentes materiais foram sintetizados para investigar a influencia de diferentes substituintes na complexação de metais e futuros estudos de eficiência biológica. Pela técnica de ressonância magnética nuclear de próton em solução, o grau de substituição dos poli-azo-compostos foi de 46 a 66%. Os compostos foram caracterizados por FT-IR e RMN de 13C no estado sólido e RMN de 15N em solução, que confirmaram a síntese dos derivados poliméricos. Também foi realizado um estudo da interação destes materiais sintetizados com os íons metálicos Cu(II) e Zn(II). Para a caracterização dos complexos, utilizou-se as técnicas de titulação complexométrica, FAAS, MEV, EDS, difratometria de raios X, EPR e TG/DTG. Por titulação complexométrica e FAAS, a quitosana pura mostrou maior capacidade em complexar/adsorver os metais do que seus derivados. A capacidade de adsorver íons Cu(II) foi maior do que íons Zn(II) para todos os compostos. Por MEV e EDS, observou-se que além do cobre coordenado pelos sítios reativos dos materiais, o sal sulfato de cobre foi adsorvido pela superfície polimérica dos mesmos. Assim, foram realizadas reações de complexação utilizando o sal CuCl2.2H2O e os resultados mostraram que esse comportamento não ocorre para este sal. Para os complexos utilizando o sal sulfato de zinco, praticamente não se observa o sal adsorvido na superfície polimérica, devido à baixa capacidade de complexação por esse metal. A difratometria de raios X mostrou uma redução da cristalinidade dos complexos de cobre e zinco formados pela quitosana e o derivado Q1Benzil devido a maior capacidade desses materiais em quelar íons metálicos. Para os complexos de Cu(II) e Zn(II) formados a partir do composto Azo-Anisidina, o índice de cristalinidade aumenta, o que pode estar associado a formação de diferentes ligações de coordenação nesse composto. A formação dos complexos também foi confirmada por espectroscopia Raman. Os espectros de EPR dos complexos de Cu(II) formados a partir do sal CuCl2.2H2O mostram a presença de uma estrutura hiperfina bem resolvida, da mesma forma que foi observado para o complexo Quitosana-CuSO4, na qual a grande maioria dos centros de cobre são monoméricos e provavelmente ligados aos polímeros. As curvas de TG/DTG mostraram que os derivados poliméricos degradam a temperaturas menores que o polímero não modificado, e os complexos com sulfato de cobre apresentaram perfis TG/DTG diferentes dos complexos sintetizados a partir do sal cloreto de cobre. Por fim, tanto a quitosana quanto seus derivados Q1Benzil, Q2Benzil e Q2Benzil utilizando a quitosana de baixo peso molecular se mostraram efetivos na síntese de carbonatos através da captura e fixação de CO2 por estes materiais poliméricos. / The present work describes structural modifications in the side chain of the polymer chitosan by N-alkylation with different aromatic aldehydes, which originates Schiff base as an intermediate, followed by reduction with sodium cyanoborohydride (NaBH3CN). Subsequently, coupling reactions between the synthesized product N-benzyl chitosan and various diazonium salts were carried out to produce a new class of poly-azo compounds from this polymer. Different materials were synthesized to investigate the influence of different substituents on metal chelation and future studies of their biological efficience. From nuclear magnetic resonance technique, the degree of substitution of the poly-azo compounds was between 46 and 66%. The compounds were characterized by FT-IR, 13C NMR in solid state and 15N NMR in solution, which confirmed the synthesis of the polymeric derivatives. The interaction of the synthesized materials with the metal ions Cu(II) and Zn(II) was also studied. For the characterization of such metal complexes, the techniques complexometric titration, FAAS, SEM, EDS, X-ray diffraction, EPR and TG/DTG were employed in this work. By complexometric titration and FAAS, pure chitosan showed greater capacity for complex/adsorb metals than its derivatives. The capacity of adsorbing Cu(II) ions was greater than Zn(II) ions for all compounds. The synthesized complexes were studied by various spectroscopic techniques. By SEM and EDS, it was observed that in addition of copper coordination, copper sulphate salt was adsorbed by the polymer surface. Thus, complexation reactions were carried out using the salt CuCl2.2H2O and the results showed that this behavior does not occur for this salt. For complexes using zinc sulfate salt, hardly observes this salt adsorbed on the polymeric surface due to the low capacity for complexing this metal. The X-ray diffraction showed a reduction of the crystallinity of copper and zinc complexes formed by chitosan and Q1Benzil derivative due to the greater ability of these materials to chelate metal ions. For the complexes of Cu(II) and Zn(II) formed from Azo-Anisidine compound, the crystallinity index increases, which can be associated with formation of different coordination bonds with the compound. The formation of the complex was also confirmed by Raman spectroscopy. EPR spectra of Cu(II) formed from the CuCl2.2H2O salt showed the presence of well resolved hyperfine structure in the same way as it was observed for chitosan-CuSO4, in which the majority of copper centers are monomeric and probably bound to the polymer. The TG/DTG curves showed that polymeric derivatives are less stable than the unmodified polymer, and complexes with copper sulfate had TG/DTG curves different from the complexes synthesized from copper chloride salt. Finally, chitosan and the derivatives Q1Benzil , Q2Benzil and Q2Benzil from low molecular weight chitosan were effective in the synthesis of carbonates through the capture and sequestration of CO2 by these polymeric materials. / FAPESP: 2012/13901-3

京都大学 / 0048 / 新制・課程博士 / 博士(工学) / 甲第18471号 / 工博第3907号 / 新制||工||1600(附属図書館) / 31349 / 京都大学大学院工学研究科物質エネルギー化学専攻 / (主査)教授 小澤 文幸, 教授 辻 康之, 教授 中村 正治 / 学位規則第4条第1項該当 / Doctor of Philosophy (Engineering) / Kyoto University / DGAM

This work presents the synthesis of three new series of nitrogen-heterocycles containing the substituent trifluoromethyl, exploiting the synthetic versatility and regioselectivity of 4-alkoxy-5-bromo-1,1,1-trifluorpent-3-en-2-ones and 4-amino-5-bromo-1,1,1-trifluoropent-3-en-2-ones in reactions with compounds containing nucleophilic nitrogen. Two series of 1-(3-alkoxy-5-trifluoromethyl-2,3-dihydrofuran-3-yl)-4,5-alkyl-3-(trifluoromethyl)-1H-pyrazoles were synthesized by the N-functionalization reaction of pyrazoles with 4-alkoxy-5-bromo-1,1,1-trifluorpent-3-en-2-ones, by Michael s nucleophilic addition. In the first step, there is a nucleophilic addition of the pyrazol molecule to the beta position of enones (Cβ), followed by an intramolecular cyclization reaction, where the furan ring is formed by replacement of the bromine atom by the carbonyl oxygen of enone, resulting in thirteen novel compounds with yields between 55-86%. The other compounds series, (E)-4-(amino)-1,1,1-trifluoro-5-(5-methyl-3- (trifluoromethyl)-1H-pyrazol-1-yl)pent-3-en-2-ones, was synthesized by N-alkylation reaction, through a bimolecular nucleophilic substitution (SN2) mechanism, with replament of the bromine atom, at five position (Cγ) of 4-amino-5-bromo-1,1,1-trifluoropent-3-en-2-ones, by the nucleophilic nitrogen of the pyrazoline ring. Seven N-alkylated products were obtained, with yields among 65-85%. In addition, the regioselectivity study of N-functionalized pyrazoles reactions is described, including the evaluation of reaction conditions and how substituents present in the pyrazole structure can influence the product formation, because many different steric and electronic factors. The obtained compounds were characterized by nuclear magnetic resonance 1H and 13C, mass spectrometry, elementary analysis and X-ray diffractometry. / A presente dissertação relata a síntese de três séries inéditas de heterociclos nitrogenados trifluormetil substituídos, que exploram a versatilidade sintética e a regiosseletividade das 4-alcóxi-5-bromo-1,1,1-trifluorpent-3-en-2-onas e das 4-amino-5-bromo-1,1,1-trifluorpent-3-en-2-onas, em reações com nucleófilos nitrogenados. As primeiras duas séries dos compostos 1-(3-alcóxi-5-trifluorometil-2,3-diidrofuran-3-il)-4,5-alquil-3-(trifluorometil)-1H-pirazóis, foram sintetizadas através do processo de N-funcionalização de pirazóis, a partir da reação com as 4-alcóxi-5-bromo-1,1,1-trifluorpent-3-en-2-onas, cujo o caminho mecanístico se deu através de uma reação de adição nucleofílica de Michael. Inicialmente, ocorre a adição do pirazol nucleofílico na posição beta (Cβ) das enonas bromadas, seguida de uma reação de ciclocondensação intramolecular formando o anel furano, com a substituição átomo de bromo pelo oxigênio enólico, resultando na formação de treze compostos inéditos, com rendimentos entre 55 e 86%. Outra série de compostos (E)-4-(amino)1,1,1-triflúor-5-(5-metil-3-(trifluormetil)-1H-pirazóis-1-il)pent-3-en-2-onas, foi sintetizada através da reação de N-alquilacão, via substituição nucleofílica bimolecular (SN2), onde o átomo de bromo na posição cinco (Cγ), das 4-amino-5-bromo-1,1,1-trifluorpent-3-en-2-onas, foi substituído pelo nitrogênio nucleofílico do anel pirazolínico, promovendo a formação de sete produtos N-alquilados, com rendimentos que variam entre 65 e 85%. Além disso, um estudo de regiosseletividade das reações N-funcionalizadas de pirazóis está descrito, onde a avaliação das condições reacionais e também de fatores estéricos e eletrônicos dos substituintes presentes nos substratos, foram determinantes para formação do produto formado. Os produtos obtidos neste trabalho foram caracterizados por ressonância magnética nuclear de 1H e 13C, espectrometria de massas de baixa e alta resolução, análise elementar e difratometria de Raio X.

By flavin's unique structure, nature predestined riboflavin and its derivatives to the participation in redox processes within the bodies of all the living organisms. These biomolecules draw attention with intriguing optical properties and photosensitising abilities. Nature-inspired flavin derivatives share these qualities, and there is also a possibility of fine-tuning for the particular application from the chemical point of view. The thesis deals with two main aims. The first aim handles the synthesis of the trimer heteroaromatic precursor and 1,2-diketone. These key intermediates are essential for the future synthesis of the central aromatic core of the novel NH-free non-fused flavin derivative. The thesis introduces and verifies three approaches, including oxidation of diarylalkynes, nucleophilic addition of a corresponding organolithium compound to a Weinreb amide and benzoin condensation. The second aim covers the properties customization of NH-free fused systems by implementation of linear and bulky alkyl side-chains on the nitrogen atoms N1 and N3 of the alloxazine dilactam. N,N-alkylation introduced an increase in solubility in common organic solvents dichloromethane and chloroform. For the derivatives with 2-(adamantan-1-yl)ethyl substituents, high thermal stability was observed via TGA.

No description available.

Les azapeptides sont des mimes peptidiques où le carbone alpha d’un ou de plusieurs acides aminés est remplacé par un atome d’azote. Cette modification tend à stabiliser une conformation en repliement beta en raison de la répulsion électronique entre les paires d’électrons libres des atomes d’azote adjacents et de la géométrie plane de l’urée. De plus, le résidu semicarbazide a une meilleure résistance face aux protéases en plus d’être chimiquement plus stable qu’une liaison amide. Bien que les propriétés des azapeptides en fassent des mimes peptidiques intéressants, leurs méthodes de synthèses font appel à la synthèse laborieuse d’hydrazines substituées en solution. Le peptide sécréteur d’hormone de croissance 6 (GHRP-6, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) est un hexapeptide synthétique qui possède une affinité pour deux récepteurs distincts: les récepteurs GHS-R1a et CD36. Les travaux effectués au cours de mon doctorat qui seront détaillés dans cet ouvrage visent à atteindre deux objectifs: (1) le développement d’analogues du peptide GHRP-6 sélectif à un seul récepteur et (2) la mise au point d’une nouvelle méthodologie pour la synthèse combinatoire d’azapeptides. En réponse au premier objectif, la synthèse parallèle de 49 analogues aza-GHRP-6 a été effectuée et certains candidats sélectifs au récepteur CD36 ont été identifiés. L’étude de leurs propriétés anti-angiogéniques, effectuée par nos collaborateurs, a également permis d’identifier des candidats intéressants pour le traitement potentiel de la dégénérescence maculaire liée à l’âge. Une nouvelle approche pour la synthèse combinatoire d’azapeptides, faisant appel à l’alkylation et la déprotection chimiosélective d’une sous-unité semicarbazone ancrée sur support solide, a ensuite été développée. La portée de cette méthodologie a été augmentée par la découverte de conditions permettant l’arylation régiosélective de cette sous-unité semicarbazone, donnant accès à treize nouveaux dérivés aza-GHRP-6 possédant des résidus aza-arylglycines aux positions D-Trp2 et Trp4. L’élaboration de conditions propices à l’alkylation et la déprotection chimiosélective de la semicarbazone a donné accès à une variété de chaînes latérales sur l’acide aminé « aza » préalablement inaccessibles. Nous avons, entre autres, démontré qu’une chaîne latérale propargyl pouvait être incorporée sur l’acide aminé « aza ». Tenant compte de la réactivité des alcynes, nous avons ensuite élaboré des conditions réactionnelles permettant la formation in situ d’azotures aromatiques, suivie d’une réaction de cycloaddition 1,3-dipolaire sur support solide, dans le but d’obtenir des mimes de tryptophane. Sept analogues du GHRP-6 ont été synthétisés et testés pour affinité au récepteur CD36 par nos collaborateurs. De plus, nous avons effectué une réaction de couplage en solution entre un dipeptide possédant un résidu aza-propargylglycine, du paraformaldehyde et une variété d’amines secondaires (couplage A3) afin d’accéder à des mimes rigides d’aza-lysine. Ces sous-unités ont ensuite été incorporées sur support solide afin de générer sept nouveaux azapeptides avec des dérivés aza-lysine à la position Trp4 du GHRP-6. Enfin, une réaction de cyclisation 5-exo-dig a été développée pour la synthèse de N-amino imidazolin-2-ones en tant que nouveaux mimes peptidiques. Leur fonctionnalisation par une série de groupements benzyliques à la position 4 de l’hétérocycle a été rendue possible grâce à un couplage Sonogashira précédant la réaction de cyclisation. Les propriétés conformationnelles de cette nouvelle famille de composés ont été étudiées par cristallographie aux rayons X et spectroscopie RMN d’un tétrapeptide modèle. L’activité biologique de deux mimes peptidiques, possédant un résidu N-amino-4-méthyl- et 4-benzyl-imidazolin-2-one à la position Trp4 du GHRP-6, a aussi été examinée. L’ensemble de ces travaux devrait contribuer à l’avancement des connaissances au niveau des facteurs structurels et conformationnels requis pour le développement d’azapeptides en tant que ligands du récepteur CD36. De plus, les résultats obtenus devraient encourager davantage l’utilisation d’azapeptides comme peptidomimétiques grâce à leur nouvelle facilité de synthèse et la diversité grandissante au niveau de la chaîne latérale des acides aminés « aza ». / Azapeptides are peptide mimics in which the CH alpha in one or more amino acids has been replaced with a nitirogen atom. Such a modification tends to induce beta turn conformations in peptides, because of the consequences of lone–pair lone–pair repulsion between the two adjacent nitrogens and the planar geometry of the urea in the semicarbazide moiety. Furthermore, the semicarbazide increases protease resistance and is chemically more stable than its amide counterpart. Despite the potential advantages of using azapeptides mimics, their synthesis has been hampered by the solution-phase construction of substituted hydrazines prior to their incorporation into peptide sequences. Growth Hormone Releasing Peptide 6 sequence (GHRP-6, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) is a synthetic hexapeptide that binds to two distinct receptor: the Growth Hormone Secretatgogue Receptor 1a (GHS-R1a) and the Cluster of Differentiation 36 (CD36) receptor. The body of my Ph.D thesis has been generally targeted towards two objectives: (a) the development of azapeptide analogs of GHRP-6 with enhanced receptor selectivity and (b) the elaboration of a new synthetic approach for combinatorial submonomer azapeptide synthesis. In response to the first objective, 49 aza-GHRP-6 derivatives were synthesized and evaluated for receptor binding and biological activity. From this library, certain candidates were identified which exhibited decreased affinity for the GHS-R1a receptor with maintained affinity for the CD36 receptor. Furthermore, in studying their anti-angiogenic properties, our collaborators have identified aza-GHRP-6 analogs, which caused a marked decrease in microvascular sprouting in choroid explants, as well as another displaying potential to increase angiogenesis. A new approach for the combinatorial synthesis of azapeptides was developed to better conduct SAR studies using azapeptides. This method features the chemoselective alkylation and deprotection of a resin-bound semicarbazone building block. The scope of the methodology was further expanded by the development of reaction conditions for the chemoselective N-arylation of this semicarbazone residue, yielding 13 aza-GHRP-6 derivatives with aza-arylglycines residues at the D-Trp2 and Trp4 positions. The elaboration of a methodology based on the chemoselective alkylation and deprotection of a semicarbazone has allowed for greater aza-amino acid side chain diversity, enabling for example, the efficient incorporation of aza-propargylglycine residues into peptide sequences. Considering the reactivity of alkynes, we developed reaction conditions for in situ formation of aromatic azides, followed by a 1,3-dipolar cycloaddition reaction on solid support to yield aza-1-aryl,2,3-triazole-3-alanine residues as tryptophan mimics. Seven aza-GHRP-6 analogs were synthesized and subsequently tested for binding to the CD36 receptor by our collaborators. Moreover, the coupling reaction between an aza-propargylglycine-containing dipeptide building block, paraformaldehyde and a variety of secondary amines (A3 coupling) was accomplished in solution to provide access to rigid aza-lysine mimics. These aza-dipeptides were subsequently incorporated at the Trp4 position of seven new aza-GHRP-6 analogues using a solid-phase protocol, and the resulting azaLys mimics were tested for binding towards the CD36 receptor. Finally, conditions for a 5-exo-dig cyclization of an aza-propargylglycine residue were developed to give N-amino imidazolin-2-ones as turn-inducing peptide mimics. Their modification at the 4 position was achieved using a Sonogashira coupling protocol prior to the cyclization step. The conformational properties of these new heterocyclic motifs were assessed by X-ray crystallography and NMR spectroscopy on a tetrapeptide model system. The incorporation of N-amino-4-methyl- and 4-benzyl-imidazolin-2-ones at the Trp4 position of GHRP-6 was further accomplished and the biological evaluation of the peptidomimetics was examined. Taken together, these results should lead to a better understanding of the structural and conformational factors responsible for binding and biological activity of azapeptide ligands of the CD36 receptor. Furthermore, the submonomer approach for azapeptide synthesis developed should promote the use of azapeptides as peptide mimics, given its accessibility and the increased aza-amino acid side-chain diversity available.

Les azapeptides sont des mimes peptidiques où le carbone alpha d’un ou de plusieurs acides aminés est remplacé par un atome d’azote. Cette modification tend à stabiliser une conformation en repliement beta en raison de la répulsion électronique entre les paires d’électrons libres des atomes d’azote adjacents et de la géométrie plane de l’urée. De plus, le résidu semicarbazide a une meilleure résistance face aux protéases en plus d’être chimiquement plus stable qu’une liaison amide. Bien que les propriétés des azapeptides en fassent des mimes peptidiques intéressants, leurs méthodes de synthèses font appel à la synthèse laborieuse d’hydrazines substituées en solution. Le peptide sécréteur d’hormone de croissance 6 (GHRP-6, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) est un hexapeptide synthétique qui possède une affinité pour deux récepteurs distincts: les récepteurs GHS-R1a et CD36. Les travaux effectués au cours de mon doctorat qui seront détaillés dans cet ouvrage visent à atteindre deux objectifs: (1) le développement d’analogues du peptide GHRP-6 sélectif à un seul récepteur et (2) la mise au point d’une nouvelle méthodologie pour la synthèse combinatoire d’azapeptides. En réponse au premier objectif, la synthèse parallèle de 49 analogues aza-GHRP-6 a été effectuée et certains candidats sélectifs au récepteur CD36 ont été identifiés. L’étude de leurs propriétés anti-angiogéniques, effectuée par nos collaborateurs, a également permis d’identifier des candidats intéressants pour le traitement potentiel de la dégénérescence maculaire liée à l’âge. Une nouvelle approche pour la synthèse combinatoire d’azapeptides, faisant appel à l’alkylation et la déprotection chimiosélective d’une sous-unité semicarbazone ancrée sur support solide, a ensuite été développée. La portée de cette méthodologie a été augmentée par la découverte de conditions permettant l’arylation régiosélective de cette sous-unité semicarbazone, donnant accès à treize nouveaux dérivés aza-GHRP-6 possédant des résidus aza-arylglycines aux positions D-Trp2 et Trp4. L’élaboration de conditions propices à l’alkylation et la déprotection chimiosélective de la semicarbazone a donné accès à une variété de chaînes latérales sur l’acide aminé « aza » préalablement inaccessibles. Nous avons, entre autres, démontré qu’une chaîne latérale propargyl pouvait être incorporée sur l’acide aminé « aza ». Tenant compte de la réactivité des alcynes, nous avons ensuite élaboré des conditions réactionnelles permettant la formation in situ d’azotures aromatiques, suivie d’une réaction de cycloaddition 1,3-dipolaire sur support solide, dans le but d’obtenir des mimes de tryptophane. Sept analogues du GHRP-6 ont été synthétisés et testés pour affinité au récepteur CD36 par nos collaborateurs. De plus, nous avons effectué une réaction de couplage en solution entre un dipeptide possédant un résidu aza-propargylglycine, du paraformaldehyde et une variété d’amines secondaires (couplage A3) afin d’accéder à des mimes rigides d’aza-lysine. Ces sous-unités ont ensuite été incorporées sur support solide afin de générer sept nouveaux azapeptides avec des dérivés aza-lysine à la position Trp4 du GHRP-6. Enfin, une réaction de cyclisation 5-exo-dig a été développée pour la synthèse de N-amino imidazolin-2-ones en tant que nouveaux mimes peptidiques. Leur fonctionnalisation par une série de groupements benzyliques à la position 4 de l’hétérocycle a été rendue possible grâce à un couplage Sonogashira précédant la réaction de cyclisation. Les propriétés conformationnelles de cette nouvelle famille de composés ont été étudiées par cristallographie aux rayons X et spectroscopie RMN d’un tétrapeptide modèle. L’activité biologique de deux mimes peptidiques, possédant un résidu N-amino-4-méthyl- et 4-benzyl-imidazolin-2-one à la position Trp4 du GHRP-6, a aussi été examinée. L’ensemble de ces travaux devrait contribuer à l’avancement des connaissances au niveau des facteurs structurels et conformationnels requis pour le développement d’azapeptides en tant que ligands du récepteur CD36. De plus, les résultats obtenus devraient encourager davantage l’utilisation d’azapeptides comme peptidomimétiques grâce à leur nouvelle facilité de synthèse et la diversité grandissante au niveau de la chaîne latérale des acides aminés « aza ». / Azapeptides are peptide mimics in which the CH alpha in one or more amino acids has been replaced with a nitirogen atom. Such a modification tends to induce beta turn conformations in peptides, because of the consequences of lone–pair lone–pair repulsion between the two adjacent nitrogens and the planar geometry of the urea in the semicarbazide moiety. Furthermore, the semicarbazide increases protease resistance and is chemically more stable than its amide counterpart. Despite the potential advantages of using azapeptides mimics, their synthesis has been hampered by the solution-phase construction of substituted hydrazines prior to their incorporation into peptide sequences. Growth Hormone Releasing Peptide 6 sequence (GHRP-6, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) is a synthetic hexapeptide that binds to two distinct receptor: the Growth Hormone Secretatgogue Receptor 1a (GHS-R1a) and the Cluster of Differentiation 36 (CD36) receptor. The body of my Ph.D thesis has been generally targeted towards two objectives: (a) the development of azapeptide analogs of GHRP-6 with enhanced receptor selectivity and (b) the elaboration of a new synthetic approach for combinatorial submonomer azapeptide synthesis. In response to the first objective, 49 aza-GHRP-6 derivatives were synthesized and evaluated for receptor binding and biological activity. From this library, certain candidates were identified which exhibited decreased affinity for the GHS-R1a receptor with maintained affinity for the CD36 receptor. Furthermore, in studying their anti-angiogenic properties, our collaborators have identified aza-GHRP-6 analogs, which caused a marked decrease in microvascular sprouting in choroid explants, as well as another displaying potential to increase angiogenesis. A new approach for the combinatorial synthesis of azapeptides was developed to better conduct SAR studies using azapeptides. This method features the chemoselective alkylation and deprotection of a resin-bound semicarbazone building block. The scope of the methodology was further expanded by the development of reaction conditions for the chemoselective N-arylation of this semicarbazone residue, yielding 13 aza-GHRP-6 derivatives with aza-arylglycines residues at the D-Trp2 and Trp4 positions. The elaboration of a methodology based on the chemoselective alkylation and deprotection of a semicarbazone has allowed for greater aza-amino acid side chain diversity, enabling for example, the efficient incorporation of aza-propargylglycine residues into peptide sequences. Considering the reactivity of alkynes, we developed reaction conditions for in situ formation of aromatic azides, followed by a 1,3-dipolar cycloaddition reaction on solid support to yield aza-1-aryl,2,3-triazole-3-alanine residues as tryptophan mimics. Seven aza-GHRP-6 analogs were synthesized and subsequently tested for binding to the CD36 receptor by our collaborators. Moreover, the coupling reaction between an aza-propargylglycine-containing dipeptide building block, paraformaldehyde and a variety of secondary amines (A3 coupling) was accomplished in solution to provide access to rigid aza-lysine mimics. These aza-dipeptides were subsequently incorporated at the Trp4 position of seven new aza-GHRP-6 analogues using a solid-phase protocol, and the resulting azaLys mimics were tested for binding towards the CD36 receptor. Finally, conditions for a 5-exo-dig cyclization of an aza-propargylglycine residue were developed to give N-amino imidazolin-2-ones as turn-inducing peptide mimics. Their modification at the 4 position was achieved using a Sonogashira coupling protocol prior to the cyclization step. The conformational properties of these new heterocyclic motifs were assessed by X-ray crystallography and NMR spectroscopy on a tetrapeptide model system. The incorporation of N-amino-4-methyl- and 4-benzyl-imidazolin-2-ones at the Trp4 position of GHRP-6 was further accomplished and the biological evaluation of the peptidomimetics was examined. Taken together, these results should lead to a better understanding of the structural and conformational factors responsible for binding and biological activity of azapeptide ligands of the CD36 receptor. Furthermore, the submonomer approach for azapeptide synthesis developed should promote the use of azapeptides as peptide mimics, given its accessibility and the increased aza-amino acid side-chain diversity available.